Rottenstein Law Group Acknowledges Inefficacy of Whole Body Vibration Therapy for Osteoporosis
(New York, NY, November 21, 2011) The Rottenstein Law Group, which represents clients with claims stemming from use of the drug Fosamax, notes with some disappointment a report that a “novel treatment known as whole-body vibration doesn’t appear to improve the bone health of postmenopausal women who are at high risk of developing osteoporosis.”
According to a November 15 report published by US News and World Report, the treatment, “which involves standing on a motorized, vibrating platform in the hop of building bone mass...showed promise in animals. But researchers, who hoped those results might translate to humans, found no benefit for women who used the platform for a year,” according to study co-author Angela M. Cheung, an internist and director of the osteoporosis program at the University of Toronto’s University Health Network.
The report notes that Dr. Joseph Lane, professor of orthopedic surgery at Weill Medical College of Cornell University, said “the study appears valid and debunks the use of whole-body therapy to treat bone loss. Currently, bisphosphonate medications such as Fosamax are the best initial treatment for bone loss...”
Fosamax is not without its own issues. Despite being the most popular osteoporosis treatment available, it has been linked to several serious side effects. In 2004, researchers found a casual connection between the drug and osteonecrosis of the jaw, or “jawbone death”, a condition where the jawbone dies due to lack of blood supply. More recently, people have been suffering low-impact femur fractures after falling from a standing height or less. Evidence is mounting that taking Fosamax or other bisphosphonate drugs to treat osteoporosis causes a significant increase in risk of this particular type of fracture of the thigh bone.
According to Merck, the manufacturer of Fosamax, as of June 30, 2011, approximately 1,650 cases, which include about 2,050 plaintiff groups, had been filed and were pending against the company in both state and federal courts.
The Rottenstein Law Group advises anyone with a friend or family member who has been prescribed Fosamax or another osteoporosis drug to recommend to that person that he or she consult a physician immediately, then speak to a qualified Fosamax lawyer. The Rottenstein Law Group lawyers have a total of more than 25 years of experience fighting for the rights of clients who have suffered harm due to the negligence of powerful corporations. Affected individuals are advised to keep apprised of the latest news concerning the Fosamax femur fracture lawsuits by checking the Fosamax Femur Fracture Lawsuit Information Center for updated information. The site is equipped with easy-to-use social media features which will enable users to spread the word about the dangers of Fosamax.
About the Rottenstein Law Group
The Rottenstein Law Group is a New York-based law firm that represents clients in mass tort actions. The firm was founded by Rochelle Rottenstein, a lawyer with over two decades of experience in compassionate representation of clients in consumer product injury, mass tort, and class action law suits. For more information, please visit their Web site, or call (888) 9-ROT-LAW.
- Contact Information
- Nava Brahe
- PR Manager
- The Rottenstein Law Group
- Contact via E-mail
This news content may be integrated into any legitimate news gathering and publishing effort. Linking is permitted.
News Release Distribution and Press Release Distribution Services Provided by WebWire.